HealthTAV®

Telomere testing for healthy aging & personalized care

Life Length’s Telomere Length Measurement is a key tool for personalized treatment and prevention of age-related diseases.

Health & aging telomere-based biomarker

384-well

Automated high-throughput confocal workflows

Single-cell

Telomere metrics
(MTL, P20)

Blood drawn

EDTA whole blood, ~8 mL

+35 countries

Have clinical availability of HealthTAV®

What is HealthTAV®?

Powered by TAT®

HealthTAV® is our telomere-measurement test based on TAT® (Telomere Analysis Technology), the world’s most accurate method to measure telomere length and multiple associated variables.

It reads individual telomeres in individual cells to deliver a precise picture of cellular health and optimize your healthspan and maximize your longevity.

Sample type

Whole blood, EDTA

Shipping kit

Kit provided with instructions for healthcare professionals

Availability

Available worldwide

What does it measure?

Median telomere length

Robust central tendency with less bias than the mean

20th percentile
Sensitive to the left tail where critically short telomeres accumulate.
Full distribution
(0–99)
Visualizes heterogeneity within the sample.
Longitudinal change

Track MTL/P20 over time to quantify response.

Telomeric Biological Age
Benchmark against age-matched cohorts to estimate telomeric age.

Who is it for?

Why telomere-based aging markers matter

HealthTAV® converts single-cell telomere information into a clear biological-age profile.

It is especially useful to establish a baseline and for longitudinal follow-up after lifestyle, supplementation or therapy—showing whether aging biology is accelerating or stabilizing.

As an objective blood test, HealthTAV® supports prevention programs and personalized medicine.

Baseline biological age
Cohort-matched percentiles
Intervention response
Verify effect size over time
Program adherence
Objective readouts to support behavior change
Risk context
Telomeres relate to aging and age-related risk

Utility & support

The benefits of using HealthTAV®

Patented technology

Our patented TAT® (HT Q-FISH) is the most precise, scalable method. The only one that measures every telomere in every cell of the sample.

Telomeric variables (TAVs)

Beyond mean length, TAT® delivers 200+ telomere metrics with clinical utility.

HealthTAV® relevance

Used as a lifestyle marker. Repeating the test tracks how aging biology changes with lifestyle and therapies, and verifies the effectiveness and adherence of prevention and personalized-medicine programs.

A complete report

Relevant information for better aging

HealthTAV® provides a detailed and objective view of your telomere biology with clinical-grade metrics. The reports show median telomere length (MTL) as a robust central measure plus average length and the burden of short telomeres (20th percentile, P20) as a key indicator of aging, senescence, and risk. Together they provide a complete telomere profile to stratify risk and personalize prevention and therapy.
Known Chronological Age
58 years old
Estimated Telomeric Biological Age
64 years old
Median Telomere Length
9,9
Kb*
Telomere Length Average
11,1
Kb*
Short Telomeres 20th Percentile
5,9
Kb*

*Kilobase, a measure of DNA length used in genetics.

Distribution graph of telomere lengths

Histogram in 500-bp bins. Your MTL and P20 are highlighted.

Graphic legend: MTL / 20th Percentile

Telomere shortening is uneven: most people have more short than long telomeres. For this reason, the median is more accurate and comparable than the average.

telomere-length-measure

Age-band comparison

Your MTL and P20 vs age-matched peers; colored bands show percentile ranges.

Your sample is at the percentile 12, which means that 12% of year-olds have shorter telomere length than yours.

Biological age estimate

Derived from MTL and the short-telomere burden (P20) against our reference population; results are interpreted against an extensive population database to provide a snapshot of how old the body is at the genetic level.

Since telomeres shorten naturally throughout life, this biological age is not easily reversed. The goal is to slow down shortening and improve key markers such as Median Telomere Length (MTL) and the proportion of short telomeres through lifestyle and preventive strategies.

Get a complete evaluation

HealthTAV®
Single-cell telomere analytics to quantify biological age (MTL & P20).
HealthOX
Oxidative-stress level from blood (ROM/UCARR) reported in severity bands.
HealthNAD+
Intracellular NAD+ to assess cellular energy and DNA-repair capacity.

Frequently Asked Questions

Telomeres vary by species and by genetics, environment, and lifestyle within a species.

They promote cellular senescence and are associated with age-related conditions: cardiovascular disease, neurodegeneration, multiple cancers (e.g., prostate, ovarian, lung), diabetes (type 1 & 2), and infertility.

Yes. HealthTAV® can be paired with HealthOX (oxidative stress, ROM/UCARR) and HealthNAD+ to build a comprehensive longevity profile and track improvement over time.
Lower oxidative stress and support repair with healthy diet, regular exercise, good sleep, stress management, and physician-guided supplementation. Some therapies (hyperbaric oxygen, ozone) are under study. HealthTAV® provides a telomere baseline (MTL, P20, distribution) and enables longitudinal tracking to quantify change with lifestyle or therapies.
Establish a baseline and repeat every 3–6 months to document response to lifestyle, supplementation or therapies.

Blasco M. (2011). María Blasco: Keeping a cap on cancer and aging. Interview by Caitlin Sedwick. The Journal of cell biology, 192(3), 370–371. https://doi.org/10.1083/jcb.1923pi

Mice with hyper-long telomeres show less metabolic aging and longer lifespans. Miguel A. Muñoz-Lorente, Alba C. Cano-Martin, Maria A. Blasco (Nature Communications, 2019). DOI: 10.1038/s41467-019-12664-x

Telomere shortening rate predicts species lifespan. Kurt Whittemore, Elsa Vera, Eva Martínez-Nevado, Carola Sanpera, Maria A. Blasco (PNAS, 2019). DOI: https://www.pnas.org/cgi/doi/10.1073/pnas.1902452116

Blasco, M. Telomerase beyond telomeres. Nat Rev Cancer 2, 627–633 (2002). https://doi.org/10.1038/nrc862

Hachmo, Y., Hadanny, A., Abu Hamed, R., Daniel-Kotovsky, M., Catalogna, M., Fishlev, G., Lang, E., Polak, N., Doenyas, K., Friedman, M., Zemel, Y., Bechor, Y., & Efrati, S. (2020). Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging, 12(22), 22445–22456. https://doi.org/10.18632/aging.202188

Got any questions?

Contact our team of experts

Are you a healthcare professional?